Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

IPO Stock Tracker

Solutions

Solutions

For Institutions

For Shareholders

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

Tetherex Pharmaceuticals Stock

tetherex.comHealthcareFounded: 2002Funding to Date: $68.65MM

Developer of drugs for the treatment of inflammatory and thrombotic diseases. The company's treatment program is built around an antibody called SelK2 directed against the cell adhesion molecule P-Selectin Glycoprotein Ligand-1 (PSGL-1).

Buy or sell Tetherex Pharmaceuticals stock Learn more about Tetherex Pharmaceuticals IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Tetherex Pharmaceuticals.

Register Today

Team

Management Team

Ziad Kawar Ph.D

Senior Scientist

Jonathan Stocker Ph.D

Senior Director, Clinical Development

Russell Rother Ph.D

President, Board Member & Chief Operating Officer

Richard Alvarez

Vice President, Operations & Research

Scott Rollins Ph.D

Chief Executive Officer, Co-Founder & Chairman

Richard Cummings Ph.D

Co-Founder

David Falconer

Vice President, Quality and Program Management

Board Members

Philip Jones MD

Scott Rollins Ph.D

Rodger McEver MD

Todd Foley

MPM Capital

David Keiser

Other companies like Tetherex Pharmaceuticals in the Healthcare sector

Sector

Last Round Est. Valuation

$2.15B

Colossal Biosciences

Sector

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$400.53MM

Sector

Last Round Est. Valuation

$4.26B

Sector

Sector

Mammoth Biosciences

Sector

Last Round Est. Valuation

$1.08B

Precision Neuroscience

Sector

Frequently Asked Questions